|
May 29
|
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
|
|
May 29
|
Where Will Amgen Be in 3 Years?
|
|
May 29
|
FDA approves Amgen’s interchangeable biosimilar Bkemv
|
|
May 28
|
Nvidia, advances in cancer research, climate change under Trump: Market Domination
|
|
May 28
|
Tapping into the GLP-1 hype? Consider these pharma stocks.
|
|
May 28
|
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
|
|
May 28
|
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
|
|
May 27
|
The Biggest Biotechnology Company in Europe
|
|
May 26
|
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
|
|
May 26
|
The Biggest Publicly Traded Biotech Company
|
|
May 25
|
It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
|
|
May 24
|
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace
|
|
May 23
|
Top Stock Reports for Apple, Mastercard & Amgen
|
|
May 22
|
Roche’s Tina-quant Lp(a) test receives FDA breakthrough device designation
|
|
May 21
|
7 Reliable Blue-Chip Stocks That Cannot Miss
|
|
Jan 15
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jan 15
|
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
|
|
Jan 15
|
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
|
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
|
Jan 12
|
Dow Jones Falls On Cool Inflation Data; Tesla Stock Slides Despite Cathie Wood Buys
|